Virology & Infectious Diseases
We are currently conducting monkeypox research, focusing on understanding the virus's mechanisms of drug-resistance. Our research aims to elucidate how monkeypox mutations associated with Tecovirimat resistance. By advancing our knowledge of monkeypox, we strive to contribute to the development of effective therapeutic interventions, enhancing our preparedness and response to this evolving infectious disease.
Our current research on respiratory viruses is dedicated to unraveling the mechanisms by which respiratory viruses, including influenza, interact with the respiratory tract and the host immune system. Our lab employs state-of-the-art techniques to enhance our ability to prevent and treat respiratory infections and mitigate their impact on public health.
Clinical Microbiology
Our lab features clinical microbiology facilities that are integral to our research and diagnostic capabilities. These facilities are equipped with advanced technologies for the identification, characterization, and monitoring of pathogenic microorganisms. Our team utilizes sophisticated diagnostic tools and high-throughput systems to perform accurate microbial analyses. These facilities play a crucial role in bridging the gap between research and patient care, ensuring that our scientific advancements contribute directly to improving clinical outcomes. By maintaining high standards of accuracy and efficiency, our clinical microbiology facilities play a pivotal role in bridging research with real-world clinical applications, ultimately enhancing patient care and public health outcomes.
Creator: Nick Iwanyshyn Copyright: © 2019 University of Toronto. All Rights ReservedCollaborations
Our lab is proud to collaborate with Mubareka Lab, a leading microbiology research facility. This partnership enhances our research capabilities by combining our advanced virology and infectious disease studies and microbial analysis techniques. This collaborative effort leverages each lab’s unique strengths and resources, fostering innovative approaches to tackling infectious diseases and driving forward advancements that benefit both scientific communities and public health initiatives.